Lynne M Mofenson
Overview
Explore the profile of Lynne M Mofenson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
170
Citations
4400
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mofenson L, Short W
Ann Intern Med
. 2024 Oct;
177(11):1588-1589.
PMID: 39374528
No abstract available.
2.
Nachega J, Mohr E, Dashraath P, Mbala-Kingebeni P, Anderson J, Myer L, et al.
N Engl J Med
. 2024 Aug;
391(14):1267-1270.
PMID: 39197097
No abstract available.
3.
Albano J, Scheuerle A, Watts D, Beckerman K, Mofenson L, Pikis A, et al.
Pharmacoepidemiol Drug Saf
. 2024 May;
33(6):e5801.
PMID: 38798093
Purpose: Antiretrovirals (ARVs) are life-saving drugs used for the treatment and prevention of HIV infection and antiviral drugs (AVs) for the treatment of chronic HBV infection. ARVs have proven highly...
4.
Short W, Zimmerman M, Mohamed O, Mofenson L
Clin Infect Dis
. 2024 May;
79(6):1472-1474.
PMID: 38709816
Antiretrovirals are often approved by the Food and Drug Administration without sufficient safety data regarding their use in pregnancy. To quantify this delay, we calculated the interval from the approval...
5.
Dadabhai S, Chou V, Pinilla M, Chinula L, Owor M, Violari A, et al.
AIDS
. 2024 Mar;
38(9):1304-1313.
PMID: 38427596
Background: IMPAACT 1077BF/FF (PROMISE) compared the safety/efficacy of two HIV antiretroviral therapy (ART) regimens to zidovudine (ZDV) alone during pregnancy for HIV prevention. PROMISE found an increased risk of preterm...
6.
van Baar J, Kostova E, Allotey J, Thangaratinam S, Zamora J, Bonet M, et al.
Hum Reprod Update
. 2023 Nov;
30(2):133-152.
PMID: 38016805
Background: Pregnant women infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are more likely to experience preterm birth and their neonates are more likely to be stillborn or admitted...
7.
8.
Nachega J, Scarsi K, Gandhi M, Scott R, Mofenson L, Archary M, et al.
Lancet HIV
. 2023 Apr;
10(5):e332-e342.
PMID: 37062293
Intramuscular injection of long-acting cabotegravir and rilpivirine is a novel, long-acting antiretroviral therapy (ART) combination approved for use as a fully suppressive regimen for people living with HIV. Long-acting cabotegravir...
9.
Eke A, Lockman S, Mofenson L
JAMA
. 2023 Apr;
329(15):1308-1309.
PMID: 37010862
No abstract available.
10.
Nachega J, Sam-Agudu N, Machekano R, Rosenthal P, Schell S, de Waard L, et al.
Clin Infect Dis
. 2022 Sep;
75(11):1950-1961.
PMID: 36130257
Background: Few data are available on COVID-19 outcomes among pregnant women in sub-Saharan Africa (SSA), where high-risk comorbidities are prevalent. We investigated the impact of pregnancy on SARS-CoV-2 infection and...